STEVEN B RATOFF
CIK 1054941 · President and CEO · last filed 2023-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.14M
Companies
2
Total Filings
32
Lifetime Open-Market Net
-$458.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 22,684 | $2.14 | $48.5K | -$699.6K | 16 | 2023-03-09 |
| NVD | Chief Executive Officer | 823,866 | $5.02 | $4.14M | $241.3K | 13 | 2009-12-14 |
Recent Filings · Page 3 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-01-26 | NVD | Grant (A) | — | $0 | EDGAR |
| 2008-12-30 | NVD | Grant (A) | — | $0 | EDGAR |
| 2008-06-23 | — | Grant (A) | — | $0 | |
| 2008-02-07 | NVD | Grant (A) | +300,000 | $0 | EDGAR |
| 2007-08-29 | NVD | Buy (P) | +5,910 | $4.3K | EDGAR |
| 2007-08-27 | NVD | Buy (P) | +6,300 | $4.1K | EDGAR |
| 2007-08-24 | NVD | Buy (P) | +39,300 | $25.5K | EDGAR |
| 2007-08-23 | NVD | Buy (P) | +4,400 | $2.8K | EDGAR |
| 2007-08-22 | NVD | Buy (P) | +50,000 | $30.4K | EDGAR |
| 2007-08-21 | NVD | Buy (P) | +25,000 | $14.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.